TIMOTHY BUSCH: Open Payments
NPI 1346201704 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 9 payments from 6 companies in 2025. Trend: 2023 $43 · 2024 $0 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Biofrontera Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Organon LLC | 2 | $31 |
| Galderma Laboratories, L.P. | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: AMELUZ, NEMLUVIO, Rhapsido, Bimzelx, OTEZLA, VTAMA.
Industry payments across NM — which companies pay providers there.
